The utility of P300 as a schizophrenia endophenotype and predictive biomarker: Clinical and socio-demographic modulators in COGS-2

Schizophrenia Research

Volumn 163, Issue 1-3, 2015, Pages 53-62

  Turetsky, Bruce I ^a   Dress, Erich M ^a   Braff, David L ^b,c   Calkins, Monica E ^a   Green, Michael F ^d,e   Greenwood, Tiffany A ^b   Gur, Raquel E ^a   Gur, Ruben C ^a   Lazzeroni, Laura C ^f   Nuechterlein, Keith H ^d   Radant, Allen D ^g,h   Seidman, Larry J ^i,j   Siever, Larry J ^k,l   Silverman, Jeremy M ^k,l   Sprock, Joyce ^b   Stone, William S ^i,j   Sugar, Catherine A ^m   Swerdlow, Neal R ^b   Tsuang, Debby W ^g,h   Tsuang, Ming T ^b,n   Light, Gregory ^b,c   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^f STANFORD UNIVERSITY   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^k MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^l VETERANS AFFAIRS MEDICAL CENTER   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ HARVARD UNIVERSITY   (United States)

more..

Author keywords

Biomarker; Endophenotype; Event related potential; P300; Schizophrenia

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; ENDOPHENOTYPE; EVOKED AUDITORY RESPONSE; FALSE NEGATIVE RESULT; FEMALE; FUNCTIONAL STATUS; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SCHIZOPHRENIA; SMOKING; SUBSTANCE USE; SYMPTOMATOLOGY; ADDICTION; BRAIN; CLINICAL TRIAL; COMPLICATION; ELECTROENCEPHALOGRAPHY; EVENT RELATED POTENTIAL; GENETICS; HEARING; MIDDLE AGED; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PRODROMAL SYMPTOM; PROGNOSIS; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SOCIOECONOMICS;

ADULT; AFRICAN AMERICANS; AUDITORY PERCEPTION; BIOMARKERS; BRAIN; ELECTROENCEPHALOGRAPHY; ENDOPHENOTYPES; EVENT-RELATED POTENTIALS, P300; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PRODROMAL SYMPTOMS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SMOKING; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 84925863576     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.09.024     Document Type: Article

References (64)

1. Anokhin A.P., Vedeniapin A.B., Sirevaag E.J., Bauer L.O., O'Connor S.J., Kuperman S., Porjesz B., Reich T., Begleiter H., Polich J., Rohrbaugh J.W. The P300 brain potential is reduced in smokers. Psychopharmacology (Berlin) 2000, 149:409-413.
2. Braff D.L., Freedman R., Schork N.J., Gottesman I.I. Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr. Bull. 2007, 33:21-32.
3. Bramon E., Rabe-Hesketh S., Sham P., Murray R.M., Frangou S. Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr. Res. 2004, 70:315-329.
4. Bramon E., Shaikh M., Broome M., Lappin J., Bergé D., Day F., Woolley J., Tabraham P., Madre M., Johns L., Howes O., Valmaggia L., Pérez V., Sham P., Murray R.M., McGuire P. Abnormal P300 in people with high risk of developing psychosis. Neuroimage 2008, 41:553-560.
5. Campanella S., Pogarell O., Boutros N. Event-related potentials in substance use disorders: a narrative review based on articles from 1984 to 2012. Clin. EEG Neurosci. 2014, 45:67-76.
6. Donchin E., Heffley E., Hillyard S.A., Loveless N., Maltzman I., Ohman A., Rösler F., Ruchkin D., Siddle D. Cognition and event-related potentials. II. The orienting reflex and P300. Ann. N. Y. Acad. Sci. 1984, 425:39-57.
7. 9-THC in humans. Neuropsychopharmacology 2012, 37:1632-1646.
8. Duncan C.C., Morisha J., Fawcett R., Kirch D. P300 in schizophrenia: state or trait marker?. Psychopharmacol. Bull. 1987, 23:497-501.
9. Ehlers C.L., Garcia-Andrade C., Wall T.L., Sobel D.F., Phillips E. Determinants of P3 amplitude and response to alcohol in Native American Mission Indians. Neuropsychopharmacology 1998, 18:282-292.
10. Fabiani M., Gratton G., Karis D., Donchin E. Definition, identification and reliability of measurement of the P300 component of the event-related brain potential. Advances in Psychophysiology 1986, 1-78. JAI Press, London. P.K. Ackles, J.R. Jennings, M.G.H. Coles (Eds.).
11. First M.B., Williams J.B.W., Spitzer R.L., Gibbon M. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Clinical Trials Version (SCID-CT) 2007, Biometrics Research, New York State Psychiatric Institute, New York.
12. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
13. Ford J.M., White P.M., Csernansky J.G., Faustman W.O., Roth W.T., Pfefferbaum A. ERPs in schizophrenia: effects of antipsychotic medication. Biol. Psychiatry 1994, 36:153-170.
14. Frangou S., Sharma T., Alarcon G., Sigmudsson T., Takei N., Binnie C., Murray R.M. The Maudsley Family Study, II: endogenous event-related potentials in familial schizophrenia. Schizophr. Res. 1997, 23:45-53.
15. Frommann I., Brinkmeyer J., Ruhrmann S., Hack E., Brockhaus-Dumke A., Bechdolf A., Wölwer W., Klosterkötter J., Maier W., Wagner M. Auditory P300 in individuals clinically at risk for psychosis. Int. J. Psychophysiol. 2008, 70:192-205.
16. Gangadhar B.N., Ancy J., Janakiramaiah N., Umapathy C. P300 amplitude in non-bipolar, melancholic depression. J. Affect. Disord. 1993, 28:57-60.
17. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 2003, 160:636-645.
18. Gratton G., Coles M.G., Donchin E. A new method for off-line removal of ocular artifact. Electroencephalogr. Clin. Neurophysiol. 1983, 55:468-484.
19. Hall R.C. Global assessment of functioning. A modified scale. Psychosomatics 1995, 36:267-275.
20. Hart C.L., Ilan A.B., Gevins A., Gunderson E.W., Role K., Colley J., Foltin R.W. Neurophysiological and cognitive effects of smoked marijuana in frequent users. Pharmacol. Biochem. Behav. 2010, 96:333-341.
21. Hedges D., Bennett D.P. Cigarette smoking and P300 amplitude in adults: a systematic review. Nicotine Tob. Res. 2014, 9:1157-1166.
22. Herning R.I., Jones R.T., Hooker W.D., Tulunay F.C. Information processing components of the auditory event related potential are reduced by cocaine. Psychopharmacology (Berlin) 1985, 87:178-185.
23. Hesselbrock V., Begleiter H., Porjesz B., O'Connor S., Bauer L. P300 event-related potential amplitude as an endophenotype of alcoholism - evidence from the collaborative study on the genetics of alcoholism. J. Biomed. Sci. 2001, 8:77-82.
24. Holshausen K., Bowie C.R., Mausbach B.T., Patterson T.L., Harvey P.D. Neurocognition, functional capacity, and functional outcomes: the cost of inexperience. Schizophr. Res. 2014, 152:430-434.
25. Jeon Y.W., Polich J. Meta-analysis of P300 and schizophrenia: paradigms, and practical implications. Psychophysiology 2003, 40:684-701.
26. Knight R.T. Aging decreases auditory event-related potentials to unexpected stimuli in humans. Neurobiol. Aging 1987, 8:109-113.
27. Kügler C.F., Taghavy A., Platt D. The event-related P300 potential analysis of cognitive human brain aging: a review. Gerontology 1993, 39:280-303.
28. Lewis R.S., Goto S.G., Kong L.L. Culture and context: East Asian American and European American differences in P3 event-related potentials and self construal. Personal. Soc. Psychol. Bull. 2008, 34:623-634.
29. Light L., Swerdlow N.R., Thomas M.L., Calkins M.E., Green M.F., Greenwood T.A., Gur R.E., Gur R.C., Lazzeroni L.C., Nuechterlein K.H., Pela M., Radant A.D., Seidman L.J., Sharp R.F., Siever L.J., Silverman J.M., Sprock J., Stone W.S., Sugar C.A., Tsuang D.W., Tsuang M.T., Braff D.L., Turetsky B.I. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in the COGS-2. Schizophr. Res. 2015, 163:63-72. (in this issue).
30. Linden D.E.J. The P300: where in the brain is it produced and what does it tell us?. Neuroscientist 2005, 11:563-576.
31. Mathalon D.H., Ford J.M., Pfefferbaum A. Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study. Biol. Psychiatry 2000, 47:434-449.
32. Mathalon D.H., Ahn K.H., Perry E.B., Cho H.S., Roach B.J., Blais R.K., Bhakta S., Ranganathan M., Ford J.M., D'Souza D.C. Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans. Front. Psychiatry 2014, 5:3. Jan 24. 10.3389/fpsyt.2014.00003.
33. Mausbach B.T., Depp C.A., Bowie C.R., Harvey P.D., McGrath J.A., Thronquist M.H., Luke J.R., Wolyniec P.S., Pulver A.E., Patterson T.L. Sensitivity and specificity of the UCSD performance-based skills assessment (UPSA-B) for identifying functional milestones in schizophrenia. Schizophr. Res. 2011, 132:165-170.
34. Mobascher A., Brinkmeyer J., Warbrick T., Wels C., Wagner M., Gründer G., Spreckelmeyer K.N., Wienker T., Diaz Lacava A., Dahmen N., Böttcher M., Thuerauf N., Clepce M., Kiefer F., De Millas W., Gallinat J., Winterer G. The P300 event-related potential and smoking-a population-based case-control study. Int. J. Psychophysiol. 2010, 77:166-175.
35. Nieman D.H., Ruhrmann S., Dragt S., Soen F., van Tricht M.J., Koelman J.H., Bour L.J., Velthorst E., Becker H.E., Weiser M., Linszen D.H., de Haan L. Psychosis prediction: stratification of risk estimation with information-processing and premorbid functioning variables. Schizophr. Bull. 2013, Oct 18, Epub ahead of print.
36. O'Connor S., Morzorati S., Christian J.C., Li T.-K. Heritable features of the auditory oddball event-related potential: peaks, latencies, morphology and topography. Electroencephalogr. Clin. Neurophysiol. 1994, 92:115-125.
37. Özgürdal S., Gudlowski Y., Witthaus H., Kawohl W., Uhl I., Hauser M., Gorynia I., Gallinat J., Heinze M., Heinz A., Juckel G. Reduction of auditory event-related P300 amplitude in subjects with at-risk mental state for schizophrenia. Schizophr. Res. 2008, 105:272-278.
38. Patterson J.V., Michalewski H.J., Starr A. Latency variability of the components of auditory event-related potentials to infrequent stimuli in aging, Alzheimer-type dementia, and depression. Electroencephalogr. Clin. Neurophysiol. 1988, 71:450-460.
39. Picton T.W. The P300 wave of the human event-related potential. J. Clin. Neurophysiol. 1992, 9:456-479.
40. Pokryszko-Dragan A., Slotwiński K., Podemski R. Modality-specific changes in P300 parameters in patients with dementia of the Alzheimer type. Med. Sci. Monit. 2003, 9:CR130-CR134.
41. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin. Neurophysiol. 2007, 118:2128-2148.
42. Polich J., Burns T. P300 from identical twins. Neuropsychologia 1987, 25:299-304.
43. Polich J., Ochoa C.J. Alcoholism risk, tobacco smoking, and P300 event-related potential. Clin. Neurophysiol. 2004, 115:1374-1383.
44. Polich J., Ladish C., Bloom F.E. P300 assessment of early Alzheimer's disease. Electroencephalogr. Clin. Neurophysiol. 1990, 77:179-189.
45. Rapaport M.H., Bazzetta J., McAdams L.A., Patterson T., Jeste D.V. Validation of the scale of functioning in older outpatients with schizophrenia. Am. J. Geriatr. Psychiatr. 1996, 4:218-228.
46. Regan D. Human Brain Electrophysiology 1989, Elsevier Science Publishing, New York.
47. Salisbury D.F., Shenton M.E., McCarley R.W. P300 topography differs in schizophrenia and manic psychosis. Biol. Psychiatry 1999, 45:98-106.
48. Segalowitz S.J., Barnes K.L. The reliability of ERP components in the auditory oddball paradigm. Psychophysiology 1993, 30:451-459.
49. Singh S.M., Basu D., Kohli A., Prabhakar S. Auditory P300 event-related potentials and neurocognitive functions in opioid dependent men and their brothers. Am. J. Addict. 2009, 18:198-205.
50. Smith M.E., Halgren E., Sokolik M., Baudena P., Musolino A., Liegeois-Chauvel C., Chauvel P. The intracranial topography of the P3 event-related potential elicited during auditory oddball. Electroencephalogr. Clin. Neurophysiol. 1990, 76:235-248.
51. Squires N.K., Squires K.C., Hillyard S.A. Two varieties of long-latency positive waves evoked by unpredictable auditory stimuli in man. Electroencephalogr. Clin. Neurophysiol. 1975, 38:387-401.
52. Swerdlow N.R., Gur R.E., Braff D.L. Consortium on the genetics of schizophrenia (COGS) assessment of endophenotypes for schizophrenia: an introduction to this special issue of schizophrenia research. Schizophr. Res. 2014, 163:9-16. (in this issue).
53. Tilki H.E., Akpolat T., Tunali G., Kara A., Onar M.K. Effects of haemodialysis and continuous ambulatory peritoneal dialysis on P300 cognitive potentials in uraemic patients. Ups. J. Med. Sci. 2004, 109:43-48.
54. Turetsky B.I., Colbath E.A., Gur R.E. P300 subcomponent abnormalities in schizophrenia: I. Physiological evidence for gender and subtype specific differences in regional pathology. Biol. Psychiatry 1998, 43:84-96.
55. Turetsky B.I., Colbath E.A., Gur R.E. P300 subcomponent abnormalities in schizophrenia: II. Longitudinal stability and relationship to symptom change. Biol. Psychiatry 1998, 43:31-39.
56. Turetsky B.I., Colbath E.A., Gur R.E. P300 subcomponent abnormalities in schizophrenia: III. Deficits in unaffected siblings of schizophrenic probands. Biol. Psychiatry 2000, 47:380-390.
57. Turetsky B.I., Calkins M.E., Light G.A., Olincy A., Radant A.D., Swerdlow N.R. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr. Bull. 2007, 33:69-94.
58. van der Stelt O., Lieberman J.A., Belger A. Auditory P300 in high-risk, recent-onset and chronic schizophrenia. Schizophr. Res. 2005, 77:309-320.
59. van Tricht M.J., Nieman D.H., Koelman J.H.T.M., van der Meer J.N., Bour L.J., de Haan L., Linszen D.H. Reduced parietal P300 amplitude is associated with an increased risk for a first psychotic episode. Biol. Psychiatry 2010, 68:642-648.
60. van Tricht M.J., Harmsen E.C., Koelman J.H., Bour L.J., van Amelsvoort T.A., Linszen D.H., de Haan L., Nieman D.H. Effects of cannabis use on event related potentials in subjects at ultra high risk for psychosis and healthy controls. Int. J. Psychophysiol. 2013, 88:149-156.
61. Venables P. Input dysfunction in schizophrenia. Progress in Experimental Personality Research 1964, 1-47. Academic Press, Orlando. B.A. Maher (Ed.).
62. Vesterager L., Christensen T.Ø., Olsen B.B., Krarup G., Melau M., Forchhammer H.B., Nordentoft M. Cognitive and clinical predictors of functional capacity in patients with first episode schizophrenia. Schizophr. Res. 2012, 141:251-256.
63. Wall T.L., Ehlers C.L. Acute effects of alcohol on P300 in Asians with different ALDH2 genotypes. Alcohol. Clin. Exp. Res. 1995, 3:617-622.
64. Zhang Y., Zhong B.L., Li Y., Ma Z.L., Tian Y., Tang J. Brain event-related potentials associated with psychiatric symptoms in amphetamine-type stimulant dependent patients. Int. J. Psychiatry Med. 2012, 43:189-196.